LIPIDATED PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR
Dossier Overview
Applicant
JANSSEN BIOTECH, INC.; PROTAGONIST THERAPEUTICS, INC.
Inventor
Santhosh NEELAMKAVIL; Chengzao SUN; Sandeep SOMANI; Stephanie A. BARROS; Raymond J. PATCH; Jing ZHANG; Douglas RIEXINGER; Charles HENDRICK; Elisabetta BIANCHI; Roberto COSTANTE; Federica ROSOLIA; Martina LOLLOBRIGIDA; Sonia DEL RIZZO; Danila BRANCA; Ashok BHANDARI; James DANIEL; Tran Trung TRAN; Brian FREDERICK
IPC Classification
CPC Classification
The present invention relates to novel lipidated peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salts, solvates and/or other forms thereof, corresponding pharmaceutical compositions, methods and/or uses of the IL-23R inhibitors for treatment of autoimmune inflammation diseases and/or related disorders.
Original (Chinese)
The present invention relates to novel lipidated peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salts, solvates and/or other forms thereof, corresponding pharmaceutical compositions, methods and/or uses of the IL-23R inhibitors for treatment of autoimmune inflammation diseases and/or related disorders.
External Resources